Showing results (61-70 of 113) with videos related to
Sort By:
Pageof 12
Cancer Research|November 1, 1977
Metabolic disposition of antipyrine in patients with lung cancerC Tschanz, C E Hignite, D H Huffman, et al.Archives Internationales De Pharmacodynamie Et De Therapie|January 1, 1977
Hepatic effects of some [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (WY-14,643) analogs in the mouseJ K Reddy, D E Moody, D L Azarnoff, et al.Annals of Internal Medicine|September 15, 1988
Effects of a low saturated fat, low cholesterol fish oil supplement in hypertriglyceridemic patients. A placebo-controlled trialW S Harris, C A Dujovne, M Zucker, et al.The Journal of Cell Biology|May 1, 1974
Nafenopin-induced hepatic microbody (peroxisome) proliferation and catalase synthesis in rats and mice. Absence of sex difference in responseJ K Reddy, D L Azarnoff, D J Svoboda, et al.Research Communications in Chemical Pathology and Pharmacology|March 1, 1975
1-methyl-4piperidyl-bis (P-chlorophenoxy) acetate: a new hypolipidemic peroxisome proliferatorJ K Reddy, T P Krishnakantha, D L Azarnoff, et al.Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1980
Pharmacokinetics of hydralazine and its acid-labile hydrazone metabolites in relation to acetylator phenotypeD D Shen, J P Hosler, R L Schroder, et al.Clinical Pharmacology and Therapeutics|April 1, 1978
Correlation between plasma diphenhydramine level and sedative and antihistamine effectsS G Carruthers, D W Shoeman, C E Hignite, et al.Journal of Chromatography|November 1, 1978
Quantitation of chlordiazepoxide and its metabolites in biological fluids by thin-layer chromatographyJ L Straughan, W F Cathcart-Rake, D W Shoeman, et al.American Heart Journal|August 30, 2001
Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemiaC A Dujovne, J H Zavoral, E Rowe, et al.Clinical Pharmacology and Therapeutics|August 1, 1984
Serum lipids in normo- and hyperlipidemics after methyldopa and propranololC A Dujovne, S DeCoursey, P Krehbiel, et al.Pageof 12